A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345.
Clinical trial NCT01587716 · COMPLETED
Trial details
- NCT number
- NCT01587716
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-23
- Primary completion
- 2012-07-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.